Neuromuscular blocking agents have been inadvertently administered to patients who were not receiving proper ventilator assistance. Because the respiratory muscles were paralyzed, some patients ...

The interleukin 17 blocking agent secukinumab has been introduced in the armentarium of antirheumatic drugs against seronegative spondylarthritis including psoriatic arthritis. Objectives To evaluate ...

Carvedilol also decreases systemic vascular resistance via its a blocking properties ... production and resultant peroxynitrite prevented interleukin lb-induced myocardial dysfunction.

Cancer cell death via necroptosis can be accompanied by the release of IL-1a, which can restrict anticancer immunity and promote tumor growth ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...

and Meta Platforms Inc. executives named /dev/agents today announced it has raised $56 million in seed funding to build what it calls an operating system for AI agents. The funding was led by ...

JAK inhibitors work by blocking the signal pathways involved in inflammation ... Various biologics are used in ulcerative colitis, including anti-TNF alpha agents, integrin receptor antagonists, ...

One of the most noteworthy and profound developments in AI innovation is the recent emergence of intelligent agents—more commonly known as AI agents—that automate and personalize customer ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...

After hours: November 29 at 4:59 PM EST ...